Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CAN: Segra awarded cannabis analytical testing licence

Segra International Corp. announced the approval of its Analytical Testing Licence from Health Canada under the Cannabis Act and Cannabis Regulations.
 
Segra's Molecular Lab opened in 2017 to provide pathogen diagnostic testing and cultivar identification services for their tissue culture facility. "These services have become a critical part of the quality assurance process that underlays our Verified Clean Stock program and now includes ten real-time PCR-based plant pathogen assays, including for HLVd. Having in-house molecular testing services is an important differentiator for Segra and provides our customers with peace of mind that they receive healthy, true-to-type, disease-free plantlets. After performing nearly 10,000 assays in the 2021-2022 fiscal year, we have upgraded our lab to increase capacity and now offer these services to our customers and other third parties looking for better crop surveillance tools."

"Our recently awarded Cannabis Analytical Testing Licence marks the official launch of Segra Molecular Lab Services, which can now test cannabis plant materials for licensed cannabis producers seeking pathogen testing and DNA fingerprinting services. What differentiates us from other testing labs is our years of experience developing methods in-house and our exclusive focus on cannabis and cannabis pathogens. We have been using Segra's molecular lab for internal purposes, and after feedback from customers, it's time to make these value-added services available for all LPs in an effort to help mitigate cultivation risks, increase supply chain security and monitor your fungal pathogen, virus and viroid load, all standard best practices in other commercially grown crops." said Jamie Blundell, CEO of Segra. "We believe that every successful plant disease mitigation strategy begins with sourcing disease-free plants and should continue with regular testing as plants mature to catch potential infections throughout the grow cycle. Segra Molecular Lab Services is more than just a testing lab. We are here to help monitor and mitigate against cannabis disease, allowing LPs to attain optimal yield and quality from every harvest."

For more information:
Segra International Corp.
segra-intl.com   

Publication date: